BIOCHEMICAL SOCIETY TRANSACTIONS discrete staining of cell bodies was found with type I sera in the newborn or 5-day-old rats. In the newborn there was a diffuse staining of the parenchyma of the developing cortex and other areas. Type I1 staining was observed, particularly in those cells with developed perikarya. By 9 days type I sera began to show, although only weakly, some cells in the cortex and hippocampus. At 14 days some of the cells in the dentate nucleus began to show type I staining, and by 21 days the staining pattern was as in the adult brain. Sera giving type I1 pattern of staining did so at all ages examined. One of the sera, which normally gave type I staining with adult brain, gave additional type I1 staining in the young brains.
Bacterial meningitis is a serious disease with a high mortality rate and a high rate of morbidity. The disease, produced by Neisseria meningitidis (meningococcus), occurs both endemically and epidemically in the population. The meningococci have been subdivided into a number of serogroups, each group being defined by their capsular polysaccharide. The chemistry and structure of the polysaccharides have now been determined. Vaccines have been prepared against the groups A and C and have proved effective in limiting epidemic disease due to these organisms. The group B meningococci share the same capsular polysaccharide antigen as Escherichia coli type K I , which is the principal agent of meningitis in the newborn. However, group B meningococcus and E . coli K 1 have been found to be poor immunogens and no really effective vaccines have yet been developed. The polysaccharide antigen of these organisms is a homopolymer of D-N-acetylneuraminic acid linked c12+8. This form of D-N-acetyheuraminic acid linkage occurs in the polysialogangliosides and in certain polysialoproteins found in the mammalian brain. It has been suggested that the poor immunogenicity of this bacterial polysaccharide is explained in part by the presence of similar structures in the host and hence immunization would require the breaking of tolerance. There is, in addition, the possibility that if produced such antibodies could, particularly in the infant, lead to autoimmune damage. Evidence has already been published to show that polysialopeptides isolated from the foetal brain will bind to horse anti-meningococci B serum, this binding being specifically blocked by polysaccharide from meningococci B or E. coli KI (Finne, et al., 1983) . By using a panel of monoclonal antibodies raised against purified bacterial Of the anti-B monoclonals tested three out of three gave positive immunofluorescence of cell surfaces after reacting them with live cultures of dissociated rat forebrain. A similar pattern of staining has been achieved with a polyvalent rabbit anti-meningococcal B serum. The cells which react with anti-B monoclonals are not stained by rabbit anti-glial fibrillary acid protein serum nor by rabbit anti-galactocerebroside serum, and are therefore neither astrocytes nor oligodendrocytes. They do bind rabbit anti-monosialoganglioside antibodies. These observations plus the numbers of stained cells and their morphology suggest that they are neurons. Double staining with anti-B type monoclonals and anti-GT, antibodies after 6 days culture shows that three groups of cells can be distinguished: ( a ) cells reactive with both anti-B antibodies and anti-GT,,, (6) cells reactive with anti-B monoclonals but not anti-GT,,, and ( c ) cells reactive with anti-GT,, but not anti-B type monoclonals.
After the pronase digestion of delipidated newborn rat brain as described by Finne (1982) a polysialopeptide fraction was isolated which on immune diffusion showed a line of identity with meningococcal B polysaccharide. The immunoblot procedure confirmed that foetal brain, but not adult brain, contained a high M , (>200000) antigen reactive with the anti-B monoclonals. It is quite likely that the cross-reactive brain molecule belongs to the class of proteins called neural cell adhesion molecules (Rutishauser, 1984) , the antibodies reacting with the polysialic acid side chain of these molecules. 
